CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $235.12 | $1.4M | 372,682 |
| 2026-05-28 | Pearce Samantha EVP, Chief Commercial Officer | Option exercise | +6,907 | $109.45 | $756K | 57,179 |
| 2026-05-28 | Pearce Samantha EVP, Chief Commercial Officer | Sale | −6,907 | $235.41 | $1.6M | 50,272 |
| 2026-05-28 | Pearce Samantha EVP, Chief Commercial Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −6,907 | 0 | ||
| 2026-05-28 | Patil Neena M EVP & Chief Legal Officer | Sale 10b5-1 | −1,192 | $236.97 | $282K | 52,626 |
| 2026-05-28 | Mulligan Seamus Director | Option exercise | +3,415 | $138.08 | $472K | 1,183,028 |
| 2026-05-28 | Mulligan Seamus Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,415 | 0 | ||
| 2026-05-22 | McSharry Heather Ann Director | Sale | −2,000 | $241.00 | $482K | 18,449 |
| 2026-05-22 | Winningham Rick E Director | Option exercise | +3,415 | $138.08 | $472K | 12,308 |
| 2026-05-22 | Winningham Rick E Director | Sale | −2,741 | $241.57 | $662K | 9,567 |
| 2026-05-22 | Winningham Rick E Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,415 | 0 | ||
| 2026-05-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $203.33 | $1.2M | 378,682 |
| 2026-04-01 | COZADD BRUCE C Director | Sale 10b5-1 | −3,684 | $190.22 | $701K | 386,998 |
| 2026-04-01 | COZADD BRUCE C Director | Sale 10b5-1 | −2,292 | $190.94 | $438K | 384,706 |
| 2026-04-01 | COZADD BRUCE C Director | Sale 10b5-1 | −24 | $191.74 | $5K | 384,682 |
| 2026-03-09 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,287 | $182.94 | $235K | 6,512 |
| 2026-03-05 | Johnson Philip L EVP & Chief Financial Officer | Shares withheld for taxes | −2,615 | $188.69 | $493K | 59,608 |
| 2026-03-05 | Henderson Mary Elizabeth SVP, Technical Operations | Shares withheld for taxes | −1,394 | $186.75 | $260K | 27,334 |
| 2026-03-05 | Pearce Samantha EVP, Chief Commercial Officer | Shares withheld for taxes | −2,503 | $188.69 | $472K | 50,272 |
| 2026-03-05 | Carr Patricia SVP, Chief Accounting Officer | Shares withheld for taxes | −1,436 | $186.77 | $268K | 7,799 |
Page 5 of 19 · 365 trades